michigan glp-1 gastric stasis lawsuit Ozempic & Gastroparesis GLP-1 Gastroparesis Lawsuit: Stomach Paralysis

despite being taken as a daily pill rather than injection, it contains the same active ingredient and allegedly carries similar risks Mounjaro (tirzepatide): Manufactured by Eli Lilly and approved in May 2022, this medication works as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, offering enhanced blood sugar control and weight loss effects but also allegedly causing severe gastrointestinal injuries similar to semaglutide products Trulicity (dulaglutide): Eli Lillys once-weekly GLP-1 injection approved in 2014 for type 2 diabetes

Among these options, the incretin-based drugs GLP-1-RA and DPP4i (which we will collectively call GLP-1 M) are widely used

Industry Response Early Hedges Morgan Stanley was early with its long-term forecast of the impact of these drugs

Your provider will collaborate with you to create a personalized health plan

Darker or larger bruises may take up to three weeks to resolve